Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 2/3 1Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Granuloma, Plasma Cell 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Crizotinib × Clear all
NCT03874273 2019-03-14

Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Unknown
25 enrolled
Plasma cell

Granuloma, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡